Evidence map›Paper›PMID 28972094›Full record

ArticleJournal of immunology (Baltimore, Md. : 1950)2017

Cytomegalovirus (CMV) Epitope-Specific CD4

Chike O Abana, Mark A Pilkinton, Silvana Gaudieri, Abha Chopra, Wyatt J McDonnell, Celestine Wanjalla, Louise Barnett, Rama Gangula, Cindy Hager, Dae K Jung and 7 more

Open access · bronzeAbstract read
In one paragraph

Article in Journal of immunology (Baltimore, Md. : 1950), 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
3.3field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 55 citations in OpenAlex.

  1. Trial
  2. The CX3CL1-CX3CR1 axis in HIV-associated inflammation and cardiometabolic disease.American journal of physiology. Regulatory, integrative and comparative physiology · 2026
    Review
  3. Review
  4. Review
  5. Mapping CMV-related immune signatures in blood, aorta and perivascular mediastinal adipose tissue.Philosophical transactions of the Royal Society of London. Series B, Biological sciences · 2025
    Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Article
  11. Review
  12. CD3bioRxiv : the preprint server for biology · 2024
    Article
  13. Review
  14. Dominant CD4Cell reports. Medicine · 2023
    Article
  15. Article
  16. Review
  17. Article
  18. CD4Frontiers in immunology · 2023
    Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors at 5 institutions in 3 countries.

Chike O AbanaDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232.ORCID 0000-0003-0209-8470
Mark A PilkintonDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232.ORCID 0000-0003-1318-8279
Silvana GaudieriDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232.ORCID 0000-0001-6873-0198
Abha ChopraInstitute for Immunology and Infectious Diseases, Murdoch University, Murdoch, Western Australia 6150, Australia.
Wyatt J McDonnellDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232.ORCID 0000-0003-3859-2067
Celestine WanjallaDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232.
Louise BarnettDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232.
Rama GangulaDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232.
Cindy HagerDivision of Infectious Diseases, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232.ORCID 0000-0002-7473-9129
Dae K JungStem Cell Transplantation, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232.
Brian G EngelhardtStem Cell Transplantation, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232.
Madan H JagasiaStem Cell Transplantation, Division of Hematology/Oncology, Department of Medicine, Vanderbilt University Medical Center, Nashville, TN 37232.
Paul KlenermanPeter Medawar Building for Pathogen Research, University of Oxford, Oxford OX1 3SY, United Kingdom; and.ORCID 0000-0003-4307-9161
Elizabeth J PhillipsDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232.
David M KoelleDepartment of Medicine, Laboratory Medicine, and Global Health, University of Washington, Seattle, WA 98195.ORCID 0000-0003-1255-9023
Spyros A KalamsDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232.ORCID 0000-0003-0098-7995
Simon A MallalDepartment of Pathology, Microbiology and Immunology, Vanderbilt University School of Medicine, Nashville, TN 37232; s.mallal@vanderbilt.edu.ORCID 0000-0002-7036-1309
Vanderbilt University Medical Center · USMurdoch University · AUVanderbilt University · USUniversity of Oxford · GBUniversity of Washington · US

Funding

Vanderbilt Institute for Clinical and Translational Research (VICTR) -Identifying correlates of functional immunity in SARS-CoV-2 convalescent plasmaUL1TR002243 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Paul A. Harris, Wesley H Self · 2017 to 2026
$130.7M
The Vanderbilt Institute for Clinical and Translational Research (VICTR)UL1TR000445 · NCATS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI BERNARD, GORDON RAPHAEL · 2012 to 2016
$41.4M
THE PERINATAL COMPLICATIONS OF ASYMPTOMATIC GENITAL HERPES SIMPLEX VIRUSP01AI030731 · NIAID · UNIVERSITY OF WASHINGTON · PI WALD, ANNA · 1991 to 2017
$34.3M
Tennessee CFAR: Implementation of Culturally Responsive Trauma-Informed Care with Youth with HIV in Memphis, TNP30AI110527 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI Stephany Norah Duda · 2015 to 2026
$27.5M
MEDICAL SCIENTIST TRAINING PROGRAMT32GM007347 · NIGMS · VANDERBILT UNIVERSITY · PI WILLIAMS, CHRISTOPHER S. · 1985 to 2023
$26.3M
Understanding and preventing HLA-associated drug reactionsP50GM115305 · NIGMS · VANDERBILT UNIVERSITY MEDICAL CENTER · PI PHILLIPS, ELIZABETH · 2015 to 2019
$13.0M
Vanderbilt Infection Pathogenesis and Epidemiology Research Training ProgramT32AI007474 · NIAID · VANDERBILT UNIVERSITY MEDICAL CENTER · PI KALAMS, SPYROS A · 1995 to 2025
$6.9M
Genomic systems approach to measure HSV-1-specific T-cell dominance in humansR01AI094019 · NIAID · UNIVERSITY OF WASHINGTON · PI KOELLE, DAVID M · 2012 to 2016
$1.9M
NCATS NIH HHS UL1 TR000445NCATS NIH HHS UL1 TR002243NIAID NIH HHS P01 AI030731NIAID NIH HHS P30 AI110527NIAID NIH HHS R01 AI094019NIAID NIH HHS T32 AI007474NIGMS NIH HHS P50 GM115305NIGMS NIH HHS T32 GM007347Wellcome Trust 109965/Z/15/Z
6 · The paper itself

Abstract

Select CMV epitopes drive life-long CD8

Indexed as

ADP-ribosyl Cyclase 1CD4-Positive T-LymphocytesCytomegalovirusCytomegalovirus InfectionsEpitopes, T-LymphocyteFemaleHIV-1HIV InfectionsHLA-DR7 AntigenHumansImmunologic MemoryMaleMembrane GlycoproteinsViral ProteinsADP-ribosyl Cyclase 1CD38 protein, humanEpitopes, T-LymphocyteHLA-DR7 AntigenMembrane GlycoproteinsViral Proteins

Identifiers

PMID28972094
PMCPMC5679304
OpenAlexW2763398558

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.